Skip to main content

2 Result(s)

within A. Patsouris Remove this filter Cancer Research Remove this filter

and

  1. No Access

    Article

    Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer

    Current guidelines recommend that patients with HER2-low metastatic breast cancer (MBC) receive sequentially two antibody–drug conjugates (ADCs): Sacituzumab Govitecan (SG) and Trastuzumab Deruxtecan (T-DXd), ...

    F. Poumeaud, M. Morisseau, L. Cabel, A. Gonçalves, C. Rivier… in British Journal of Cancer (2024)

  2. No Access

    Article

    Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutation

    Efficacy of endocrine therapy in HR+/HER2− metastatic breast cancer could differ depending on the presence of BRCA1/2 germline mutation.

    J.-S. Frenel, A. Lusque, S. Delaloge, J.-M. Ferrero… in British Journal of Cancer (2023)